Substitutions like Non-GMO can be inferior or harmful

Henry Miller | Forbes | 
Many supposedly health-conscious consumers who choose products with labels like “BPA-Free” or “non-GMO” may be getting less than they bargained ...

Chemophobe activists vilify glyphosate, herbicide less toxic than many ‘natural’ alternatives

Henry Miller | Forbes | 
The latest scare tactic of the chemophobe lobby promotes the fear of chemicals in food. They seem oblivious to the ...

Proposed New York bill misguided attack on GMOs, vaccines

Faye Flam | Forbes | 
In a bizarre juxtaposition of irrational fears, a New York State legislator has introduced a bill to ban GMOs in ...

FDA approval of 23andMe’s genetic test positive sign for the genomics industry

Matthew Herper | Forbes | 
On February 19, the Food and Drug Administration approved a test made by 23andMe, the Mountain View, Calif.-based personal genetics company, ...

IBM, Mars collaborate to figure out what makes food safe

Jeff Welser | Forbes | 
Is your food safe? Protecting the global food supply is a monumental public health challenge. In the U.S. alone, one ...

How prevalent is the belief in creationism today?

Forbes | 
Dr. Amy Unsworth is a research fellow at the Faraday Institute for Science and Religion, St. Edmund’s College, Cambridge University ...
child cellphone medium idge

No scientific basis behind claims that Wi-Fi signals cause cancer

Faye Flam | Forbes | 
Last week, several media outlets including Forbes.com ran with an alarming-if-true story that equated the low frequency radiation emitted by Wi-Fi ...

Low vaccination rates linked to rapidly spreading California Disneyland measles outbreak

Tara Haelle | Forbes | 
Most people have heard by now that two dozen individuals who visited Disneyland between Dec. 15 and Dec. 20, 2014, ...

Why new guidelines for sharing clinical trial data are important

Judy Stone | Forbes | 
We're in the middle of a major flu epidemic, and the CDC has recommended treatment with an antiviral (e.g., Tamiflu ...

23andMe enters biopharmaceutical business with Genentech deal

Matthew Herper | Forbes | 
A deal being announced today with Genentech points the way for 23andMe, the personal genetics company backed by Facebook billionaire ...
cancer

What are the implications of the ‘bad luck’ cancer study?

Geoffrey Kabat | Forbes | 
It’s not every day that a scientific paper forces us to re-examine long-held views on a topic of great importance ...

Can this year’s flu vaccine quell the present pandemic?

David Kroll | Forbes | 
As you’ve likely heard by now, the 2014-2015 influenza season is on a fast pace, now defined as a pandemic ...

Harvard stem cell researchers challenge accusations of scientific misconduct

Larry Husten | Forbes | 
Two embattled and highly controversial stem cell researchers are suing the Brigham and Women’s Hospital and Harvard Medical School for ...

Tracking disease outbreaks through city’s sewer system

Patrick Welsh | Forbes | 
Disease prevention and mapmaking have been inextricably intertwined since 1854, when an English physician named John Snow plotted a cholera ...

Big Data shows value for farmers and industry

Howard Baldwin | Forbes | 
Who knew that the specific crossover of agriculture and big data was such a big deal? Everyone from Mother Jones ...

New app will let doctors review patients’ genome for cancer treatment

Matthew Herper | Forbes | 
Patrick Soon-Shiong, the richest doctor in the world, and Blackberry Chief Executive John Chen made some news at Thursday’s Forbes ...
bee by ishyam

EPA accomplice in environmentalists’ war on neonics?

Henry Miller | Forbes | 
The Environmental Protection Agency is arguably the worst regulatory agency in the history of the world. But perhaps I understate ...

Repurposing genetics to search for ‘healthy’ genes

David Shaywitz | Forbes | 
For most us, the scientific promise associated with understanding the human genome exists in uneasy tension with the quiet terror ...

Over-regulation of ag biotechnology squanders billions of dollars

Henry Miller | Forbes | 
The big agribusiness companies have achieved “regulatory capture” of government agencies–but not in the way that many people think. At ...
Evie Beach e

‘Miracle’ drug grows young girls limbs, costs of rare disease treatments pose challenges

Matthew Herper | Forbes | 
Evie Elsaesser is 5 years old and she loves to run. And that is a medical miracle. When Evie was born, ...

Story of Darwinian evolution, as told by coffee plants

F.D. Flam | Forbes | 
Charles Darwin did a fine job of showing why his theory of evolution explained the living world better than any ...

Cancer genome sequencing advancing personalized treatment

Elaine Schattner | Forbes | 
As the cost of DNA sequencing plummets, the possibility of testing all cancer patients’ tumor genomes is becoming a reality ...
ec c a dd bdbd f fd e

What happens when 100 billion animals, over 18 years, eat GMOs?

Jon Entine | Forbes | 
Visit almost any anti-GMO website and you will find alarming headlines about the alleged dangers of GMO foods. They kill ...

Pipeline drugs for ovarian cancer will genetically match patients

Elaine Schattner | Forbes | 
September is Ovarian Cancer Awareness Month. You might not notice. Ovarian cancer shares the back-to-school educational National Health Observances slot with ...
Human genome

Genome sequencing is getting cheaper, but might make healthcare more expensive

Peter Ubel | Forbes | 
Cheaper genomic sequencing will give more patients and their physicians access to genetics in the healthcare system. But will that ...

Economics of genetic testing and medicine

Peter Ubel | Forbes | 
The first time scientists sequenced a person’s entire genome, it took more than a decade and cost hundreds of millions ...

European ‘green groups’ block science reform over independent advisor backing of GE research

Trevor Butterworth | Forbes | 
It is, perhaps, not the best of times for Greenpeace. Many of its supporters are angered at the revelation that ...
Agarose gel with UV illumination Ethidium bromide stained DNA glows orange close up

FDA to regulate genetic diagnostic tests, will affect cancer testing

Matthew Herper | Forbes | 
The Food and Drug Administration unveiled plans to regulate thousands of diagnostic tests, including many coming from the exploding field ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists